tbuckley/cabot-search huggingface dataset:
Upregulation of Myt1 Promotes Acquired Resistance of Cancer Cells to Wee1 Inhibition
Authors: Cody W. Lewis, Amirali B. Bukhari, Edric J. Xiao, Won-Shik Choi, Joanne D. Smith, Ellen Homola, John R. Mackey, Shelagh D. Campbell, Armin M. Gamper, Gordon K. Chan
Journal: Cancer Research (2019)

Abstract Adavosertib (also known as AZD1775 or MK1775) is a small-molecule inhibitor of the protein kinase Wee1, with single-agent activity in multiple solid tumors, including sarcoma, glioblastoma, and head and neck cancer. Adavosertib also shows promising results in combination with genotoxic agents such as ionizing radiation or chemotherapy. Previous studies have investigated molecular mechanisms of primary resistance to Wee1 inhibition. Here, we investigated mechanisms of acquired resistance to Wee1 inhibition, focusing on the role of the Wee1-related kinase Myt1. Myt1 and Wee1 kinases were both capable of phosphorylating and inhibiting Cdk1/cyclin B, the key enzymatic complex required for mitosis, demonstrating their functional redundancy. Ectopic activation of Cdk1 induced aberrant mitosis and cell death by mitotic catastrophe. Cancer cells with intrinsic adavosertib resistance had higher levels of Myt1 compared with sensitive cells. Furthermore, cancer cells that acquired resistance following short-term adavosertib treatment had higher levels of Myt1 compared with mock-treated cells. Downregulating Myt1 enhanced ectopic Cdk1 activity and restored sensitivity to adavosertib. These data demonstrate that upregulating Myt1 is a mechanism by which cancer cells acquire resistance to adavosertib. Significance: Myt1 is a candidate predictive biomarker of acquired resistance to the Wee1 kinase inhibitor adavosertib.
Donor CD8+ T Cells Mediate GVL without GVHD in Recipients Conditioned with Anti-CD3 mAb.
Authors: Chunyan Zhang, Jingwei Lou, Naninong Li, Ivan Todorov, Chia-Lei Lin, Yu-An Cao, Christopher H. Contag, Fouad Kandeel, Stephen Forman, Defu Zeng
Journal: Blood (2006)
Microenvironment-Dependent Synthetic Lethality: Implications for Tumor Pathophysiology and Anti-Cancer Drug Discovery.
Authors: Douglas McMillin, Jake Delmore, Ellen Weisberg, Joseph M. Negri, Steffen Klippel, Nicholas Mitsiades, Nikhil C. Munshi, James D Griffin, Paul G. Richardson, Kenneth C. Anderson, Andrew L. Kung, Constantine S. Mitsiades
Journal: Blood (2009)
High Impact of Matching Score On Different HSCT Outcomes After Single and Double Umbilical Cord Blood Transplantation for Hematological Malignancies
Authors: Mauricette Michallet, Mohamad Sobh, Stephane Morisset, Hélène Labussière-Wallet, Marie Y. Detrait, Valerie Dubois, Jean-Paul Bourgeot, Sophie Ducastelle, Fiorenza Barraco, Youcef Chelghoum, Valerie Mialou, Valérie Chapelle, Sothiny Sar, Olivier Hequet, Xavier Thomas, Franck E. Nicolini, Yves Bertrand
Journal: Blood (2012)
The first step of precision medicine with blood based genomic sequencing assay in a Japanese local university hospital
Authors: Nahomi Tokudome, Hiroki Ueda, Yasuhiro Koh, Yuichi Ozawa, Kenji Matsuda, Minami Sawako, Miwako Miyasaka, Murata Shinichi, Yuta Hamano, Nobuyuki Yamamoto
Journal: Annals of Oncology (2019)
Fludarabine, Cyclophosphamide and Rituximab in Waldenström’s Macroglobulinemia: An Effective Regimen Requiring a New Category of Response Criteria and a Delayed Assessment of Results
Authors: Alessandra Tedeschi, Sara Miqueleiz, Francesca Ricci, Annalisa Luraschi, Mario Schiavone, Alessandro Andriani, Maria Teresa Petrucci, Felicetto Ferrara, Enrica Morra
Journal: Blood (2007)
Safety and Efficacy of CEEP (Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) with or without Rituximab in Elderly Patients (&gt;70) with Diffuse Large B-Cell Lymphoma (DLBL): A Retrospective Single Center Experience
Authors: Danny Hsu, Ibrahim Tohidi-Esfahani, Christina Brown, Scott Dunkley, Stephen Robert Larsen, Phoebe Joy Ho, Harry Iland, John Gibson, Douglas E. Joshua
Journal: Blood (2011)
Complete Remission After First-Line Radio Plus Chemotherapy Is Enough to Improve Survival in Extra Nodal NK/T Cell lymphoma
Authors: Adrien Chauchet, Anne-Sophie Michallet, Francoise Berger, Isabelle Bedgedjian, Eric Deconinck, Catherine Sebban, Daciana Antal, Hubert Orfeuvre, Bernadette Corront, Tony Petrella, Maya Hacini, Marie Bouteloup, Gilles Andre Salles, Bertrand Coiffier
Journal: Blood (2011)
Characterization of CD9-CXCL12-CXCR4 Expression in Biological Subtypes of Childhood ACUTE Lymphoblastic Leukemia: Preliminary Findings and Future Perspectives
Authors: Valeria Iachelli, Nellina Andriano, Paola Bonaccorso, Manuela La Rosa, Emanuela Cannata, Piera Samperi, Milena La Spina, Andrea Di Cataldo, Giovanna Russo, Luca Lo Nigro
Journal: Blood (2016)
Impact of Bone Marrow Fibrosis and Early Response on Outcome after Azacitidine Therapy in 94 Patients with Myelodisplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
Authors: Gianluigi Reda, Marta Riva, Ramona Cassin, Bruno Fattizzo, Martina Pennisi, Diana Giannarelli, Alfredo Molteni, Alessandra Freyrie, Roberto Cairoli, Agostino Cortelezzi
Journal: Blood (2016)
17p Deleted Multiple Myeloma: Clinical Outcomes and Predictive Factors For Acquisition Of 17p Deletion
Authors: Vincent Rajkumar, Rhett P Ketterling, Angela Dispenzieri, Martha Q Lacy, Morie A Gertz, Francis K Buadi, David Dingli, Suzanne R Hayman, Prashant Kapoor, Arleigh McCurdy, Nelson Leung, John A Lust, Stephen J. Russell, Steven R Zeldenrust, Yi Lin, Robert Kyle, Macp, Shaji K Kumar
Journal: Blood (2013)
Red/Far‐Red Light Switchable Cargo Attachment and Release in Bacteria‐Driven Microswimmers
Authors: Oya Ilke Sentürk, Oliver Schauer, Fei Chen, Victor Sourjik, Seraphine V. Wegner
Journal: Advanced Healthcare Materials (2019)

Abstract In bacteria‐driven microswimmers, i.e., bacteriabots, artificial cargos are attached to flagellated chemotactic bacteria for active delivery with potential applications in biomedical technology. Controlling when and where bacteria bind and release their cargo is a critical step for bacteriabot fabrication and efficient cargo delivery/deposition at the target site. Toward this goal, photoregulating the cargo integration and release in bacteriabots using red and far‐red light, which are noninvasive stimuli with good tissue penetration and provide high spatiotemporal control, is proposed. In the bacteriabot design, the surfaces of E. coli and microsized model cargo particles with the proteins PhyB and PIF6, which bind to each other under red light and dissociate from each other under far‐red light are functionalized. Consequently, the engineered bacteria adhere and transport the model cargo under red light and release it on‐demand upon far‐red light illumination due to the photoswitchable PhyB–PIF6 protein interaction. Overall, the proof‐of‐concept for red/far‐red light switchable bacteriabots, which opens new possibilities in the photoregulation in biohybrid systems for bioengineering, targeted drug delivery, and lab‐on‐a‐chip devices, is demonstrated.
A Multicentre Study Investigating the Pharmacokinetics and Pharmacodynamics of Busulphan When Combined with Melphalan As Conditioning in Adult Autologous Transplant Recipients
Authors: Abbey Willcox, Eric Wong, Ashish R Bajel, Simon J. Harrison, Rosemary Thurston Hoyt, Brett Janson, Christa Nath, Peter J Shaw, David Ritchie, Andrew Grigg
Journal: Blood (2016)
Use of a Fc-Optimized CD19 Antibody for Treatment of MRD in Pediatric Patients with B-Lineage Acute Lymphoblastic Leukemia
Authors: Peter Lang, Heiko-Manuel Teltschik, Patrick Schlegel, Ursula Seidel, Ludger Grosse-Hovest, Steffen Aulwurm, Martin Hofmann, Rouwen Teltschik, Kai Witte, Hans-Georg Rammensee, Gundram Jung, Rupert Handgretinger
Journal: Blood (2012)
In Patients With Chronic Lymphocytic Leukemia (CLL) Ibrutinib Effectively Reduces Clonal IgM Paraproteins and Serum Free Light Chains While Increasing Normal IgM, IgA Serum Levels, Suggesting a Nascent Recovery Of Humoral Immunity
Authors: Georg Aue, Mohammed Farooqui, Jade Jones, Janet Valdez, Sabrina E. Martyr, Susan Soto, Maryalice Stetler-Stevenson, Constance Yuan, Adrian Wiestner
Journal: Blood (2013)
Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
Authors: Fernando Bril, Michael J. McPhaul, Michael P. Caulfield, Virginia C. Clark, Consuelo Soldevilla-Pico, Roberto J. Firpi-Morell, Jinping Lai, Dov Shiffman, Charles M. Rowland, Kenneth Cusi
Journal: Diabetes Care (2019)

OBJECTIVE The 2019 Standards of Medical Care in Diabetes suggested that patients with nonalcoholic fatty liver disease (NAFLD) should be evaluated for liver fibrosis. However, the performance of noninvasive clinical models/scores and plasma biomarkers for the diagnosis of nonalcoholic steatohepatitis (NASH) and advanced fibrosis has not been carefully assessed in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS In this cross-sectional study, patients (n = 213) had a liver MRS, and those with a diagnosis of NAFLD underwent a percutaneous liver biopsy. Several noninvasive clinical models/scores and plasma biomarkers were measured to identify NASH and advanced fibrosis (NASH: ALT, cytokeratin-18, NashTest 2, HAIR, BARD, and OWLiver; advanced fibrosis: AST, fragments of propeptide of type III procollagen [PRO-C3], FIB-4, APRI, NAFLD fibrosis score, and FibroTest). RESULTS None of the noninvasive tools assessed for the diagnosis of NASH in patients with T2DM had an optimum performance (all areas under the curve [AUCs] &amp;lt;0.80). Of note, none of the panels or biomarkers was able to outperform plasma ALT (AUC 0.78 [95% CI 0.71–0.84]). Performance was better to diagnose advanced fibrosis, in which plasma PRO-C3, AST, and APRI showed better results than the other approaches (AUC 0.90 [0.85–0.95], 0.85 [0.80–0.91], and 0.86 [0.80–0.91], respectively). Again, none of the approaches did significantly better than plasma AST. Sequential use of plasma AST and other noninvasive tests may help in limiting the number of liver biopsies required to identify patients with advanced fibrosis. CONCLUSIONS Performance of noninvasive clinical models/scores and plasma biomarkers for the diagnosis of NASH or advanced fibrosis was suboptimal in patients with T2DM. Combination of multiple tests may provide an alternative to minimize the need for liver biopsies to detect fibrosis in these patients.
House dust mites activate nociceptor–mast cell clusters to drive type 2 skin inflammation
Authors: Nadine Serhan, Lilian Basso, Riccardo Sibilano, Camille Petitfils, James Meixiong, Chrystelle Bonnart, Laurent L. Reber, Thomas Marichal, Philipp Starkl, Nicolas Cenac, Xinzhong Dong, Mindy Tsai, Stephen J. Galli, Nicolas Gaudenzio
Journal: Nature Immunology (2019)
Reinduction Chemotherapy for AML: Comparison Between CECA, High Dose Cytarabine and CLAG-M
Authors: Christina Escobar, Sukanthini Subbiah, Maxim Norkin, Helen Leather, Ashley Richards, Randy A. Brown, W. Stratford May, John R. Wingard, Jack W Hsu, Christopher R Cogle
Journal: Blood (2011)
Pooled RCTs: In acute ischemic stroke with salvageable brain tissue, alteplase at 4.5 to 9 hours improved function
Authors: John R. Absher
Journal: Annals of Internal Medicine (2019)

Source Citation Campbell BC, Ma H, Ringleb PA, et al; EXTEND, ECASS-4, and EPITHET Investigators. Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging: a systematic review a...
Concurrent Opioid and Benzodiazepine Prescriptions Among Older Women Diagnosed With Breast Cancer
Authors: Devon K Check, Aaron N Winn, Nicole Fergestrom, Katherine E Reeder-Hayes, Joan M Neuner, Andrew W Roberts
Journal: JNCI Journal of the National Cancer Institute (2019)

Abstract Guidelines recommend using caution in co-prescribing opioids with benzodiazepines, yet, in practice, the extent of concurrent prescribing is poorly understood. Notably, no population-based studies, to our knowledge, have investigated concurrent prescribing among patients with cancer. We conducted a retrospective cohort study using data from the Surveillance, Epidemiology, and End Results (SEER) database linked with Medicare claims (2012–2016) for women diagnosed with breast cancer. We used modified Poisson regression to examine predictors of any concurrent prescriptions in the year post-diagnosis and Poisson regression to examine predictors of the number of overlapping days. We found that 13.0% of the 19 267 women in our sample had concurrent prescriptions. Women who underwent more extensive treatment and those with previous use of opioids or benzodiazepines were at increased risk for concurrent prescriptions (adjusted risk ratio of previous benzodiazepine use vs no previous use = 15.05, 95% confidence interval = 13.19 to 17.19). Among women with concurrent prescriptions, overlap was most pronounced among low-income, rural, and Hispanic women (adjusted incidence rate ratio of Hispanic vs non-Hispanic white = 1.25, 95% confidence interval = 1.20 to 1.30). Our results highlight opportunities to reduce patients’ unnecessary exposure to this combination.
Combined extradural-interdural-intradural approach to a trigeminal nerve cystic haemangiopericytoma with intra-operative cranial nerve monitoring
Authors: Joseph Frantzias, José Lavrador, Noémia Pereira, Richard Gullan, Keyoumars Ashkan, Francesco Vergani, Ranjeev Bhangoo, Nick Thomas
Journal: Neuro-Oncology (2019)

Abstract Objectives Haemangiopericytoma of the trigemimal nerve is extremely rare, with only two previous cases described to our knowledge. We present the surgical approach to this tumour, and describe a previously poorly reported method of monitoring the function of the branches of the trigeminal nerve: mapping of the sensory roots through transcranial somatosensory cortex sensory evoked potentials (SSEPs), motor evoked potentials (MEP) for the motor root and blink reflex. Design Case and technical reports Subjects 32 year-old male patient presenting with headaches and vomiting, found to have a mixed cystic-solid tumour of the left middle skull base region, in close relation with the foramen ovale and Meckel’s cave. Methods The radiological features of the tumour, technical aspects of the technical approach and neurophysiologic monitoring will be described. Results A pterional craniotomy with fronto-temporal extradural-interdural-intradural approach, and the tumour was debulked with MEP, SSEP and blink reflex monitoring of the branches of the trigeminal nerve. Complete tumour removal was achieved with no post-operative cranial nerve deficits. The histopathology revealed a cystic haemangiopericytoma. Conclusions Haemangiopericytoma is a rare entity. MEP and SSEP monitoring of the trigeminal nerve can be used to achieve complete and safe removal of the tumour.
Marked Therapeutic Efficacy of a Novel Polyethyleneglycol-SN38 Conjugate, EZN-2208, in Xenograft Models of Non-Hodgkin’s Lymphoma.
Authors: Puja Sapra, Mary Mehlig, Jennifer Malaby, Patricia Kraft, Clifford Longley, Hong Zhao, Lee M. Greenberger, Ivan D. Horak
Journal: Blood (2007)
Azacitidine (AZA) and Decitabine (DAC) Show Differential Effects On DNA Methyltransferase (DNMT) Levels in Patients with High Risk (HR) Myelodysplastic Syndrome (MDS)
Authors: Aileen Cohen, Ying-Wen Huang, Rachael E. Hawtin, Jodi R. Ware, Alessandra Cesano, Steven M. Kornblau
Journal: Blood (2012)
Impact of Routine Surveillance Imaging on Outcomes in Patients with Classical Hodgkin Lymphoma (cHL) Undergoing Autologous Hematopoietic Cell Transplantation (auto-HCT)
Authors: Jonathan Kapke, Narendranath Epperla, Namrata Shah, Kristin Richardson, George Carrum, Parameswaran Hari, Mehdi Hamadani, Sai Ravi Pingali, Reem Karmali, Timothy S. Fenske
Journal: Blood (2015)
Uncomplicated Arthroplasty—an Artist’s Perspective
Authors: Frances McGuire
Journal: JAMA (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incidence and Risk Factors for Central Nervous System Manifestation in Elderly Patients with Aggressive Non-Hodgkin’s Lymphoma.
Authors: E. Ösby, H. Hagberg, S. Kvalöy, L. Teerenhovi, H. Anderson, E. Cavallin-Ståhl, H. Holte, J. Myhre, Å. Öst, H. Pertovaara, M. Björkholm
Journal: Blood (2005)
Long-Term Memory Deficits and Early Onset Dementia in Aging Adult Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Cranial Irradiation
Authors: Gregory T. Armstrong, Petersen C. Ronald, Nan Zhang, Aimee Santucci, Deokumar Srivastava, Wilburn E. Reddick, Robert J. Ogg, Claudia M. Hillenbrand, Noah D. Sabin, Matthew J. Krasin, Larry Kun, Ching-Hon Pui, Melissa M. Hudson, Leslie L. Robison, Kevin R. Krull
Journal: Blood (2012)
Antiphospholipid Antibodies, Platelet and Endothelial Activation in Acute Thrombotic Thrombocytopenic Purpura (TTP).
Authors: Carlos J. Bidot, Wenche Jy, Joaquin J. Jimenez, Lawrence Horstman, Eugene Ahn, Gabriela Lander, Miriam Yaniz, Vincenzo Fontana, Yeon S. Ahn
Journal: Blood (2004)
Long Term Follow-up of High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation for Patients with Mantle Cell Lymphoma
Authors: Ryan D. Cassaday, Philip A. Stevenson, Theodore A. Gooley, Thomas Chauncey, John Pagel, Brian G. Till, Mary Philip, Johnnie J. Orozco, William I. Bensinger, Leona Holmberg, Andrei R. Shustov, Damian J. Green, Stephen D. Smith, Edward N. Libby, David G Maloney, Lorinda A. Soma, Oliver W. Press, Ajay K. Gopal
Journal: Blood (2014)
HDAC6 Inhibition Increases Translation of CD20 mRNA and Potentiates the Efficacy of Anti-CD20 Immunotherapy
Authors: Malgorzata Bobrowicz, Joanna Stachura, Michal Dwojak, Antoni Domagala, Beata Pyrzynska, Elise Berthel, Nicole Dalla Venezia, Marta Siernicka, Malgorzata Firczuk, Magdalena Winiarska
Journal: Blood (2016)
Human CD4+ T Cells Help CD8+ T Cells Proliferate Ex Vivo by Secreting Both IL-2/IL-21 and Upregulating IL-21R
Authors: Marcus O. Butler, Osamu Imataki, Yoshihiro Yamashita, Makito Tanaka, Sascha Ansén, Alla Berezovskaya, Matthew I. Milstein, Genita Metzler, Mary M. Mooney, Andrew P. Murray, Hiroyuki Mano, Lee M. Nadler, Naoto Hirano
Journal: Blood (2010)
Graded PU.1 Levels Regulate Granulocyte Vs. Macrophage Genes Via Multiple Enhancer Elements
Authors: Vitek Pospisil, Pavle Krsmanovic, Jan Valecka, Kamila Chramostová, Vojtech Kulvait, Jiri Zavadil, Martin Vokurka, Peter Laslo, Tomas Stopka
Journal: Blood (2016)
Acquired Mutation and Reversion of the Neutrophil Elastase Gene, ELA2, in Kostmann Syndrome and Cyclic Neutropenia Suggest that Some Mutations Cause Neutropenia while Others Paradoxically Suppress It.
Authors: Kathleen F. Benson, Kayleen Williams, Joanna Luty, Valeh Hadavi, Roxana Kariminejad, Mohammad H. Kariminejad, Marshall Horwitz
Journal: Blood (2004)
Modeling Breast Cancer Using CRISPR-Cas9–Mediated Engineering of Human Breast Organoids
Authors: Johanna F Dekkers, James R Whittle, François Vaillant, Huei-Rong Chen, Caleb Dawson, Kevin Liu, Maarten H Geurts, Marco J Herold, Hans Clevers, Geoffrey J Lindeman, Jane E Visvader
Journal: JNCI Journal of the National Cancer Institute (2019)

Breast cancer is characterized by histological and functional heterogeneity, posing a clinical challenge for patient treatment. Emerging evidence suggests that the distinct subtypes reflect the repertoire of genetic alterations and the target cell. However, the precise initiating events that predispose normal epithelium to neoplasia are poorly understood. Here, we demonstrate that breast epithelial organoids can be generated from human reduction mammoplasties (12 out of 12 donors), thus creating a tool to study the clonal evolution of breast cancer. To recapitulate de novo oncogenesis, we exploited clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 for targeted knockout of four breast cancer-associated tumor suppressor genes (P53, PTEN, RB1, NF1) in mammary progenitor cells from six donors. Mutant organoids gained long-term culturing capacity and formed estrogen-receptor positive luminal tumors on transplantation into mice for one out of six P53/PTEN/RB1-mutated and three out of six P53/PTEN/RB1/NF1-mutated lines. These organoids responded to endocrine therapy or chemotherapy, supporting the potential utility of this model to enhance our understanding of the molecular events that culminate in specific subtypes of breast cancer.
Higher Rates of AML Transformation and Poor Risk Cytogenetics in Patients with Low Average Albumin Levels Confers Poor Prognosis in Myelodysplastic Syndromes,
Authors: Manoj Bupathi, Valeria Visconte, Fabiola Traina, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Ramon V. Tiu
Journal: Blood (2011)
Pegylated Interferon a2a (PegIFN) At the Dose of 45μg Per Week in Combination with Imatinib 400mg Is the Recommended Initial Dose for Patients (pts) with Chronic Phase Chronic Myeloid Leukemia (CML-CP): Results From the French SPIRIT Trial of the French CML Group (FI LMC)
Authors: Hyacinthe Johnson-Ansah, Joelle Guilhot, Philippe Rousselot, Rea Delphine, Francoise Rigal-Huguet, Franck E. Nicolini, Anne Vekhoff, Agnès Guerci-Bresler, Michele Schoenwald, Eric Jourdan, Laurence Legros, Valérie Coiteux, Francois-Xavier Mahon, Claude Preudhomme, Francois Guilhot
Journal: Blood (2011)
Various immuno-related adverse events after IPI+NIVO therapy; a case report of metastatic choroidal melanoma
Authors: Yumi Yoshii, Shunsuke Okazaki, Yuki Nakatani, Yuko Tsuboguchi, Kohei Akiyoshi, Shinya Ueda, Shinya Tokunaga, Masataka Shimozono, Hitoshi Goto, Kazuyoshi Fukai, Haruko Daga
Journal: Annals of Oncology (2019)
Decitabine Is Superior to Cytotoxic Chemotherapy in Elderly Acute Myeloid Leukemia Patients in Terms of Medical Source Utilization and Cost-Effectiveness without Negatively Impacting Survival Outcomes
Authors: Youngil Koh, Young Ae Kim, Kyuwoong Kim, Jin-Ah Sim, Sung-Soo Yoon, Sang Min Park, Young Ho Yun
Journal: Blood (2016)
Quantification of Serum IgMκ and IgMλ In Patients with Waldenstrom's Macroglobulinemia (WM) at Diagnosis and During Disease Course; Clinical Correlations
Authors: Efstathios Koulieris, Marie-Christine Kyrtsonis, Dimitris Maltezas, Tatiana Tzenou, Ladan Mirbahai, Nikolitsa Kafassi, Vassiliki Bartzis, Maria Dimou, George Georgiou, Charis Matsouka, Gerasimos Pangalis, Panayiotis Panayiotidis, Arthur Bradwell, Stephen Harding
Journal: Blood (2010)
A Novel Role for Mesenchymal Stem/Progenitor Cells As Hypoxia Sensors During Initiation of Neo-Vasculogenesis in Vivo
Authors: Nicole A Hofmann, Anna Ortner, Rodrigo Jacamo, Andreas Reinisch, Katharina Schallmoser, Rokhsareh Rohban, Margareta Frühwirth, Nathalie Liechtenstein, Christine Beham-Schmid, Werner Linkesch, Michael Andreeff, Dirk Strunk
Journal: Blood (2012)
A Prospective Phase II Comparison of Stem Cell Source Using Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) RE—Induction, Then High Dose Fludarabine, Busulfan (FLUBU) and Autologous (ASCT) or Allogeneic (AlloSCT) Hematopoietic Blood Stem Cell Transplantation for Mantle Cell (MCL) and Relapsed Low-Grade B-Cell Non-Hodgkin’s Lymphoma (NHL).
Authors: Douglas A. Stewart, Michael Voralia, Ahsan Chaudhry, Oluyemi Jeje, Donald Morris, Lynn Savoie, Chris Brown, Wanda Hasagawa, Nizar Bahlis, James R. Russell
Journal: Blood (2004)